NEWS
Healio | Low-dose PAX-101 improves autism spectrum disorder symptoms in boys

Boys with autism spectrum disorder who received 10 mg/kg of a suramin IV infusion known as PAX-101 experienced greater improvements in symptoms than those who received 20 mg/kg of the same treatment or placebo, data show. According to the CDC, one in 54 children in the U.S. had ASD in 2016, up from one in 150 children […]

DNAWeekly | Exploring RNA-Based Oncology Treatments With Cartesian Therapeutics

Cartesian Therapeutics is a fully integrated, clinical-stage biopharmaceutical company developing novel cell and gene immunotherapies to treat cancer and autoimmune diseases. In this interview CEO Dr. Murat Kalayoglu discusses the uniqueness of RNA cell therapy and its potential to completely eliminate cancer once and for all. Please describe the company’s story, mission, and goals. What sparked the […]

Healthcare IT News | How one company hopes to use childbirth simulators to improve patient health

Gaumard Scientific vice president Jim Archetto said the goal is to place providers into the kind of “low-frequency, high-risk” environment they might not often encounter in a clinical setting. Despite medical and technological advancements, the United States has continued to face a maternal health crisis. In fact, the rate of maternal mortality has been increasing in […]